The Indian pharmaceutical market has shown growth of a little over 20 per cent for the 12 months ended July, above four times the global growth rate of about five per cent.
This unprecedented rate could attract more global companies to enter the domestic drug market, thus triggering more buyouts of Indian companies by multinational drug makers, said industry experts.
This unprecedented rate could attract more global companies to enter the domestic drug market, thus triggering more buyouts of Indian companies by multinational drug makers, said industry experts.